Experimental peptide receptor radionuclide therapy in radioiodine negative somatostatin receptor positive thyroid cancer

被引：0
|
作者：
Nilica, B. [1 ]
Kroiss, A. [1 ]
Putzer, D. [1 ]
Uprimny, C. [1 ]
Warwitz, B. [1 ]
Kendler, D. [1 ]
Waitz, D. [1 ]
Virgolini, I. [1 ]
机构：
[1] Univ Klin Nukl Med, Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuro-endocrine Tumors
    Giovacchini, Giampiero
    Nicolas, Guillaume
    Forrer, Flavio
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (05) : 526 - 542
  • [42] Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs
    Kwekkeboom, DJ
    Mueller-Brand, J
    Paganelli, G
    Anthony, LB
    Pauwels, S
    Kvols, LK
    O'Dorisio, TM
    Valkema, R
    Bodei, L
    Chinol, M
    Maecke, HR
    Krenning, EP
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 : 62S - 66S
  • [43] Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues: ten years experience
    Bodei, Lisa
    Grana, Chiara M.
    Bartolomei, Mirco
    Baio, Silvia M.
    Sierra, Maribel Lopera
    Paganelli, Giovanni
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (08) : 524 - 524
  • [44] Initial experience with somatostatin receptor (SSTR) imaging and peptide receptor radionuclide therapy for patients with neuroendocrine differentiation (NED) of prostate cancer
    Assadi, M.
    Rekabpour, S.
    Ahmadzadehfar, H.
    Jafari, E.
    Amini, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S696 - S697
  • [45] Peptide receptor radionuclide therapy in radioiodine refractory thyroid cancer: A case report of significant response to lu177 DOTA TATE treatment
    Aghaee, A.
    Nakhaei, S. Ataei
    Aryana, K.
    Mostafavi, S.
    Kosari, H. Mohammadzadeh
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S10 - S11
  • [46] Diagnosis and Treatment of Lung Neuroendocrine Neoplasms Somatostatin Receptor PET Imaging and Peptide Receptor Radionuclide Therapy
    Park, Hyesun
    Subramaniam, Rathan M.
    [J]. PET CLINICS, 2023, 18 (02) : 223 - 231
  • [47] Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
    Ahmadi Bidakhvidi, Niloefar
    Goffin, Karolien
    Dekervel, Jeroen
    Baete, Kristof
    Nackaerts, Kristiaan
    Clement, Paul
    Van Cutsem, Eric
    Verslype, Chris
    Deroose, Christophe M.
    [J]. CANCERS, 2022, 14 (01)
  • [48] Somatostatin Receptor Based Imaging and Radionuclide Therapy
    Xu, Caiyun
    Zhang, Hong
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [49] Somatostatin receptor radionuclide therapy in neuroendocrine tumors
    Haider, Mintallah
    Das, Satya
    Al-Toubah, Taymeyah
    Pelle, Eleonora
    El-Haddad, Ghassan
    Strosberg, Jonathan
    [J]. ENDOCRINE-RELATED CANCER, 2021, 28 (03) : R81 - R93
  • [50] 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy
    Astrid Capello
    Eric Krenning
    Bert Bernard
    Jean-Claude Reubi
    Wout Breeman
    Marion de Jong
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 1288 - 1295
12345